Number of recipients |
3,414 |
4,683 |
7,125 |
|
Mortality |
|
|
|
|
30-day |
122 (3.57%) |
182 (3.89%) |
245 (3.44%) |
0.440 |
1-year |
325 (9.52%) |
406 (8.67%) |
616 (8.65%) |
0.293 |
Long-term |
558 (16.34%) |
692 (14.78%) |
1053 (14.78%) |
0.080 |
Posttransplant follow up, years |
2.43 (1.03- 4.00) |
2.15 (1.02- 4.00) |
2.48 (1.03- 4.00) |
|
Re-transplant |
18 (0.53%) |
20 (0.43%) |
50 (0.70%) |
0.142 |
Median time to retransplant, years |
1.83 (0.02- 3.60) |
1.90 (0.05-
2.90) |
1.87 (0.02- 3.40) |
|
Hospital length of stay, days |
24.0 ± 29.2 |
22.3 ± 24.3 |
21.1 ± 22.9 |
<0.001 |
Average waitlist time, days |
337 ± 442 |
268 ± 386 |
188 ± 325 |
<0.001 |
Renal failure requiring dialysis |
429 (12.57%) |
655 (13.99%) |
882
(12.38%) |
0.031 |
Permanent pacemaker |
95 (2.78%) |
142 (3.03%) |
196 (2.75%) |
0.647 |
Stroke |
92 (2.69%) |
144 (3.07%) |
206 (2.89%) |
0.601 |
Reoperation |
126 (3.69%) |
172 (3.67%) |
255 (3.58%) |
0.945 |
One-year drug-treated acute rejection |
416 (12.19%) |
601 (12.83%) |
705 (9.89%) |
<0.001 |
Drug-treated infection |
244 (7.15%) |
335 (7.15%) |
461 (6.47%) |
0.252 |